AstraZeneca
AZN
#53
Rank
โ‚ฌ249.94 B
Marketcap
161,16ย โ‚ฌ
Share price
-1.43%
Change (1 day)
30.78%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ249.94 Billion

As of May 2026 AstraZeneca has a market cap of โ‚ฌ249.94 Billion. This makes AstraZeneca the world's 53th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ249.94 B1.99%
2025โ‚ฌ245.05 B25.25%
2024โ‚ฌ195.66 B3.4%
2023โ‚ฌ189.22 B-3.52%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-4.92%
2011โ‚ฌ46.60 B-4.74%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On May 22nd, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ500.24 Billion
by Nasdaq info icon info icon
โ‚ฌ249.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ486.09 B 94.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ249.93 B 0.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ127.20 B-49.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ131.19 B-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ818.36 B 227.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ91.21 B-63.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ24.64 B-90.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ260.51 B 4.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ104.62 B-58.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ88.84 B-64.45%๐Ÿ‡ฌ๐Ÿ‡ง UK